Medgenics (MDGN)

[Djfab]

Medgenics Inc. Commo (MDGN) rises quickly following the company’s announcement that its Infradure Biopump has been given an Orphan Drug Designation from the FDA in order to treat hepatitis D. This designation allows the company to be given grant money, obtain specific tax credits, seven years of market exclusivity, and possibly an expedited regulatory process. The designations has made Seeking Alpha contributor Ray Dirks label Medgenics as a prime takeout target. The shares closed at $8.65, up $1.75 or 25.36% on the day. They have traded in a 52-week range of $2.08 to $8.60